Physicians, researchers, and public health experts from Columbia University weigh in on what we now know about the novel coronavirus and what we still need to learn.
Columbia researchers have isolated antibodies from COVID-19 patients that neutralize SARS-CoV-2 virus and could be used to treat patients or prevent infections.
Dr. David Ho, scientific director and CEO of the Aaron Diamond AIDS Research Center, talks with Rachel Maddow about using antibodies from COVID-19 survivors against new coronavirus infections.
Hispanic mothers had higher rates of COVID-19 than other groups of women, but ethnicity had no effect on outcomes among 100 women with COVID-19 who delivered at two hospitals in northern Manhattan.
Columbia dental students in the Hispanic Student Dental Association are finding ways to promote oral health in the community during the COVID-19 pandemic without compromising safety.
“People, depending on their ideology on school opening, are choosing which evidence to present — and that needs to be avoided,” said Jeffrey Shaman, an epidemiologist at Columbia University.
Columbia virologist Vincent Racaniello, host of the podcast "This Week in Virology," interviewed Anthony Fauci, NIAID director, about our current understanding of COVID-19 and progress with vaccines.
One of the office's first initiatives is to assemble advisory deans to provide career guidance and resources to VP&S faculty seeking professional development opportunities.
“We have to find a balance between preserving safety and living,” said Dr. Linda Fried, a geriatrician and the dean of the Mailman School of Public Health at Columbia University.
Madelyn Gould’s research into the effectiveness of suicide hotlines helped pave the way for 988, a new nationwide suicide hotline number that will become operational in 2022.
